Endocrine-Related Cancer
 |
|
|
Former names
|
Reviews on Endocrine-Related Cancer |
|---|---|
|
Abbreviated title (ISO 4)
|
Endocr.-Relat. Cancer |
| Discipline | Oncology, endocrinology |
| Language | English |
| Edited by | Charis Eng |
| Publication details | |
| Publisher |
Bioscientifica on behalf of the Society for Endocrinology
|
|
Publication history
|
1994-present |
| Frequency | Bimonthly |
| 5.267 | |
| Indexing | |
| ISSN |
1351-0088 (print) 1479-6821 (web) |
| CODEN | ERCAE9 |
| OCLC no. | 40802577 |
| Links | |
Endocrine-Related Cancer is a monthly peer-reviewed medical journal covering cancers in endocrine organs — such as the breast, prostate, pituitary, testes, ovaries, and neuroendocrine system — and hormone-dependent cancers occurring elsewhere in the body. Its scope covers basic, translational, clinical and experimental studies.
The journal is published by Bioscientifica on behalf of the Society for Endocrinology. It is also an official journal of the European Society of Endocrinology and the Japanese Hormone and Cancer Society. The editor-in-chief is Charis Eng (Cleveland Clinic) and, according to the ISI Journal Citation Reports, the journal has a 2016 impact factor of 5.267.
Endocrine-Related Cancer was founded as Reviews on Endocrine-Related Cancer, the in-house journal of Zeneca (now AstraZeneca) published by its parent company ICI Pharmaceuticals. It was taken over by the Society for Endocrinology in 1994 when it was renamed, and the remit was extended to include a limited number of original research articles to complement the existing reviews. The numbers of research articles gradually increased over time.
...
Wikipedia